| Name | Title | Contact Details |
|---|
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Tropiclean Pet Products, a division of Cosmos Corporation, has been providing pet owners and professionals with innovative solutions in the pet care category for over 20 years.
Access 2 Care is a Lincoln Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioAbility is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Claflin Canada is a Niagara Falls, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.